The News

The News

Portfolio Companies in the News

» 15/05/12
First quarter 2012 topline, scientific activity and upcoming clinical data

» 10/05/12
DBV Technologies welcomes Charles Ruban as Chief Development Officer

» 12/05/12
Un Français dans le gotha mondial des investisseurs

» 26/04/12
Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study

» 25/04/12
Nanobody for Alzheimer's disease from the alliance with Boehringer Ingelheim moves closer towards Phase I clinical trials

» 12/04/12
Atos rachète la start-up française BlueKiwi

» 04/04/12
Ablynx's Partner shows that a nanobody can elicit superior anti-tumour efficacy compared to conventtionzl monoclonal antibody approaches

» 04/04/12
NOXXON's NOX-A12 Delays Glioblastoma Recurrence in Preclinical Model

» 02/04/12
Ablynx receives milestone payment as collaborator receives IND approval for a nanobody in oncology

» 29/03/12
Sofinnova Partners' portfolio company DBV Technologies successfully raises €40.5M in its oversubscribed IPO

» 26/03/12
STENTYS Self-Apposing™ technology supported by breaking new scientific evidence

» 22/03/12
Avantium and Danone sign development partnership for Next Generation bio-based plastic: PEF

» 21/03/12
Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID)

» 28/02/12
Clinical Development Program receives FDA “Fast Track Designation” and encouraging phase Ib safety results for Viaskin Peanut

» 22/02/12
BioAmber Closes $30 Million Financing with LANXESS and Existing Investors

» 22/02/12
ReCor Medical announces CE mark approval for its novel PARADISE™ ultrasound transcatheter renal denervation system

» 17/02/12
Great success for the initial public offering of INSIDE SECURE, which raises 69 million euros on NYSE Euronext Paris

» 14/02/12
Is Data Throttling a Necessary Evil for Cellphone Carriers?

» 10/01/12
Omthera Pharmaceuticals announces Positive Long Term Bioavailability data comparing Epanova™ to Lovaza®

Click here for the site of Sofinnova Ventures, our sister firm in San Francisco http://www.sofinnova.com